Greater acceptance of chronic pain is associated with fewer pain-related difficulties, such as distress and disability, and better quality of life. Pragmatically, however, the idea that one might want to be more “accepting” of chronic pain runs contrary to common sense. To help clarify this confusion the McAuley Group, which researches low back pain at NeuRA, is proud to be […]
Read more
Obstructive sleep apnoea (OSA) is the most common type of sleep apnoea and is caused by obstruction of the upper airway. What we know about OSA involves repeated episodes of upper airway obstruction during sleep. Common symptoms of OSA are excessive daytime sleepiness, snoring, waking unrefreshed, and waking during the night choking or gasping for air. OSA occurs in at […]
Read more
The number of Australians with dementia is predicted to grow to more than one million people in the next 40 years. NeuRA researcher Professor Glenda Halliday believes we’re in a better position than ever before to discover how to diagnose the many different dementias and reduce the number of people who will be affected in the future. With more than […]
Read more
Using fNIRS opens doors and provides new opportunities for studying brain activity that was not previously possible. Autism spectrum disorder, or ASD, is a complex developmental disability; signs typically appear during early childhood and affect the ability to communicate and interact with others. There is no known single cause of autism, but increased awareness and early diagnosis and intervention lead […]
Read more
This article originally appeared on The Brain Dialogue. Suzanne Shubart. Now brain travellers can track their explorations with highly-detailed maps created with state-of-the-art imaging technology. The Big Picture You’re lost in the desert and, after wandering for days, in the distance you spot a giant red rock jutting out of the barren landscape. Had you never encountered this landmark before […]
Read more
NSW Minister for Medical Research, Pru Goward, today announced an investment of $2.5 million to fund a landmark merger between Australia’s leading schizophrenia research organisations – NeuRA – Neuroscience Research Australia and the Schizophrenia Research Institute (SRI). “The best outcomes for the treatment of schizophrenia will be achieved through the opportunity of these institutes to join forces and share their […]
Read more
This year’s grant application round is over – drawing sighs of relief from our researchers who are paid through competitive grants from the National Health and Medical Research Council (NHMRC) and other agencies. Writing a grant application is analogous to submitting a tender: researchers are competing to have the best ideas and most relevant projects supported. With only one in […]
Read more